600594 益佰製藥
按盤價 
4.800 +0.440 (+10.092%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -3.538 | -11.805 | 3.599 | -14.140 | 7.472 |
| 總資產報酬率 ROA (%) | -2.181 | -7.295 | 2.227 | -9.137 | 4.899 |
| 投入資產回報率 ROIC (%) | -2.478 | -8.338 | 2.563 | -10.474 | 5.532 | 邊際利潤分析 |
| 銷售毛利率 (%) | 60.323 | 61.848 | 69.471 | 70.963 | 78.754 |
| 營業利潤率 (%) | -6.215 | -14.363 | 4.870 | -13.745 | 9.424 |
| 息稅前利潤/營業總收入 (%) | -5.326 | -14.386 | 5.245 | -13.116 | 10.182 |
| 淨利潤/營業總收入 (%) | -6.265 | -15.394 | 3.239 | -16.442 | 6.896 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 65.617 | 78.423 | 150.494 | -53.505 | 144.023 |
| 價值變動淨收益/利潤總額(%) | 0.388 | -0.102 | 0.022 | 0.042 | 11.161 |
| 營業外收支淨額/利潤總額(%) | 3.332 | 6.095 | -3.807 | 4.107 | -1.624 | 償債能力分析 |
| 流動比率 (X) | 1.877 | 1.844 | 2.226 | 1.740 | 1.593 |
| 速動比率 (X) | 1.249 | 1.204 | 1.595 | 1.207 | 1.080 |
| 資產負債率 (%) | 34.462 | 36.432 | 34.347 | 35.839 | 30.754 |
| 帶息債務/全部投入資本 (%) | 22.791 | 23.892 | 21.841 | 25.137 | 20.305 |
| 股東權益/帶息債務 (%) | 309.808 | 290.853 | 328.028 | 281.679 | 379.863 |
| 股東權益/負債合計 (%) | 181.684 | 166.696 | 182.676 | 170.342 | 221.220 |
| 利息保障倍數 (X) | -4.825 | -15.831 | 9.479 | -10.769 | 11.209 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 34.107 | 34.643 | 33.286 | 41.814 | 35.376 |
| 存貨周轉天數 (天) | 271.233 | 259.207 | 253.296 | 267.364 | 266.560 |
| 備註： | 即時報價更新時間為 02/04/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
